Sugi Predict
/ Targets
/ EPCAM
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to EPCAM by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer |
PHASE1/PHASE2 | RECRUITING |
| IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer |
PHASE2 | UNKNOWN |
| Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer. |
PHASE2 | WITHDRAWN |
| Enfortumab Vedotin With or Without Pembrolizumab in Rare Genitourinary Tumors (E-VIRTUE) |
PHASE2 | RECRUITING |
| Intraperitoneal Infusion of EpCAM CAR-T Cell in Advanced Gastric Cancer With Peritoneal Metastasis (WCH-GC-CART) |
PHASE1 | UNKNOWN |
| Safety of AM-928 Infusion in Advanced Solid Tumors |
PHASE1 | RECRUITING |
| Can E-cadherin Found in Tissue/Blood be Valuable in Identifying & Monitoring Patients With Post-proton Pump Inhibitor (PPI)-Responsive Heartburn |
PHASE1 | COMPLETED |
| Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors |
PHASE1 | UNKNOWN |
| Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer |
PHASE1 | COMPLETED |
| A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1- and EpCAM-positive Solid Tumors |
nan | UNKNOWN |
| Immunohistochemical Expression of Epithelial Cell Adhesion Molecule (EpCAM) in Epithelial Ovarian Carcinoma |
nan | UNKNOWN |
| Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study |
nan | COMPLETED |
| Circulating Tumor Cell Detection in Patients With Luminal A Breast Cancer |
nan | RECRUITING |
| Silicon Microsieve Device vs Cell Surface Marker-based Platform for the Isolation of Pancreatic Cancer CTCs |
nan | UNKNOWN |
| Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic Adenocarcinoma |
nan | COMPLETED |
| Expression of Epithelial-Mesenchymal Transition Associated Markers in Peri-implant Tissues |
nan | RECRUITING |
| Prognostic Value of Liver Cancer CTCs Isolated by a Novel Microfluidic Platform |
nan | UNKNOWN |
| Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry |
nan | ACTIVE_NOT_RECRUITING |
| Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device |
nan | UNKNOWN |
| Epithelial Mesenchymal Transition Markers in OSMF |
nan | COMPLETED |
| Influence of EMT on CTCs and Disease Progression in Prostate Cancer |
nan | COMPLETED |
| Circulating Tumor Cells in Operative Blood |
nan | COMPLETED |
| Determination of Blood Tumor Cells |
nan | COMPLETED |
| Study Evaluating the Efficacy and Safety With CAR-T for Stomach Cancer |
nan | UNKNOWN |
| Monocentric Retrospective Observational Study for Validation of Meta-analysis of the Metatrascryptome and Transcriptome of Eosynophyl Esophagitis |
nan | UNKNOWN |
| VETC, Prognostic and Predictive Value in Renal Cell Carcinoma and Adrenal Carcinoma |
nan | UNKNOWN |
| Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA |
nan | RECRUITING |
| Profiling Gingival Crevicular Fluid β-Catenin Level With 8-OHdG and Total Antioxidants Capacity During Healing of Periodontal Pockets: A 3-month Clinical Trial |
nan | NOT_YET_RECRUITING |
| Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression |
nan | COMPLETED |
| Early Diagnosis of Pancreatic Cancer Via Deciphering Multi-modal Immunological Signatures |
nan | NOT_YET_RECRUITING |
Related proteins — ESM-2 sequence neighbours (a EPCAM binder may also engage these)